Feed aggregator

ASCO 2021: Fate Therapeutics Stock Jumps on Positive Data from Lymphoma Study

Biospace news - Mon, 06/07/2021 - 02:00
Shares of Fate climbed nearly 4% in premarket trading after it announced positive interim data from a Phase I study of FT516 for patients with relapsed / refractory B-cell lymphoma.

Clinical Catch-Up: June 1-6

Biospace news - Mon, 06/07/2021 - 02:00
With the 2021 American Society of Clinical Oncology meeting held late last week, there is plenty of clinical trial news.

Merck Investigating Noose Reportedly Found at Durham, North Carolina Plant

Biospace news - Mon, 06/07/2021 - 02:00
An ugly symbol of racism appears to have reared its head at a Merck facility in North Carolina. The pharma giant is investigating reports of a noose found hanging at a construction project on the 262-acre facility.

Novartis Showcases Multiple Clinical Programs At ASCO

Biospace news - Mon, 06/07/2021 - 02:00
Novartis flexed its clinical muscles over the weekend, announcing results from multiple studies including different types of cancer and kidney disease.

FDA approves new drug treatment for chronic weight management, first since 2014

World Pharma News - Fri, 06/04/2021 - 10:00
Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity.

Another COVID-19 Win for Regeneron as FDA Okays Lower Dose of Antibody Cocktail

Biospace news - Fri, 06/04/2021 - 02:00
REGEN-COV's 1,200 mg dose is authorized to treat mild-to-moderate COVID-19 in adults and children 12 years and older who weigh 40 kilograms or more.

CVR Holders Slap BMS with Lawsuit After Missed Liso-Cel Deadline

Biospace news - Fri, 06/04/2021 - 02:00
It didn’t take too long before a lawsuit was filed over Bristol Myers Squibb’s failure to meet a deadline for a $9 Contingent Value Rights agreement tied to the company’s merger with Celgene.

HIV Epidemic: 40 Years Later

Biospace news - Fri, 06/04/2021 - 02:00
On June 5, the world marks the 40th anniversary of the HIV epidemic. Biopharma researchers continue to develop safe and effective treatments with an eye to a potential cure.

ASCO Update: A Theme of Accessibility and Pricing Plus Individual Reporting

Biospace news - Fri, 06/04/2021 - 02:00
With the 2021 American Society of Clinical Oncology Annual Meeting now in high gear, there is plenty of news. Here’s a look at just some of the most recent stories.

Experts: Previous COVID-19 Infection Not a 'Get Out Of Jail Free' Card

Biospace news - Fri, 06/04/2021 - 02:00
Importantly, the researchers recovered virus that they were able to culture, indicating a high risk for transmissibility.

Three Biopharma Companies Raise Millions in Separate Series A Financing Rounds

Biospace news - Fri, 06/04/2021 - 02:00
​The three companies will aim to develop their different programs such as Stablix TPS platform, Stellanova's focused on targeting pro-tumorigenic effects, and Amyl's development of preclinical therapeutic candidates.

Bayer Acquires Noria, PSMA Therapeutics to Expand Place in Prostate Cancer Space

Biospace news - Fri, 06/04/2021 - 02:00
Bayer will nab exclusive rights to a differentiated alpha radionuclide, actinium-225 investigational compound, and a small molecule targeting prostate-specific membrane antigen.

Nanobiotix’s Radiotherapy Enhancer for Tumors Also Primes the Immune System

Biospace news - Fri, 06/04/2021 - 02:00
Nanobiotix is developing a way for its locally-injected radioenhancer for solid tumors to treat metastasized cancers, in combination with checkpoint inhibitors, and also deliver results distally.

Bayer at ASCO: Vitrakvi Effective in TRK Fusion Cancers Regardless of Tumor Type

Biospace news - Fri, 06/04/2021 - 02:00
Bayer, like many biopharma companies, is presenting study results at the 2021 American Society of Clinical Oncology (ASCO) Annual meeting being held online June 4-8, 2021.

Research Roundup: A Complete Human Genome Sequenced and More

Biospace news - Fri, 06/04/2021 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

BioSpace Movers & Shakers, June 4

Biospace news - Fri, 06/04/2021 - 02:00
Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

Global Acceptance for Sinovac's COVID-19 Vaccine Grows Despite Disparate Data

Biospace news - Fri, 06/04/2021 - 02:00
While several countries rely on Sinovac Biotech to end the pandemic, concerns regarding the shot’s efficacy continue to shroud the vaccine. Currently, it is the second most used vaccine worldwide.

NIH researchers identify potential new antiviral drug for COVID-19

World Pharma News - Thu, 06/03/2021 - 12:00
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health. TEMPOL can limit SARS-CoV-2 infection by impairing the activity of a viral enzyme called RNA replicase. The work was led by researchers at NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The study appears in Science.

How to obtain immune bovine milk to strengthen the body against COVID-19

World Pharma News - Thu, 06/03/2021 - 10:00
Physiologically, milk contains biocomponents that are highly protective against infections. In light of this, the AGR-149-Infectious Diseases group at the University of Cordoba's Department of Animal Health is doing research that focuses on cow's milk as a possible source of COVID-19 control. The results have been published, partially, in the journal Frontiers in Immunology.

White House Science Chief Wants to Nullify Next Pandemic Within 100 Days

Biospace news - Thu, 06/03/2021 - 02:00
The nation’s top science adviser believes the country’s renewed enthusiasm for science may pave the way for plug-and-play vaccines that can nullify the next pandemic before it starts.